Data collection

Next DLP Announces First Security Solution to Automatically Map to MITRE's Insider Threat Knowledge Base

Retrieved on: 
Tuesday, April 30, 2024

BOSTON and LONDON, April 30, 2024 /PRNewswire-PRWeb/ -- Next DLP ("Next"), a leader in data loss prevention and insider threat solutions, today announced that their Reveal Platform is the first Insider Risk Management solution to automatically map detection events to MITRE Engenuity Center for Threat-Informed Defense's ("Center") expanded Insider Threat Knowledge Base (ITKB 2.0). The ITKB 2.0 is the first of its kind to offer an evidence-based, multi-organizational and publicly-available compendium of insider threat tactics, techniques, and procedures (TTPs). This endeavor was developed in partnership between MITRE, Next DLP, CrowdStrike, HCA Healthcare, JPMorgan Chase Bank, N.A., Lloyds Banking Group, Microsoft Corporation and Verizon Business.

Key Points: 
  • BOSTON and LONDON, April 30, 2024 /PRNewswire-PRWeb/ -- Next DLP ("Next"), a leader in data loss prevention and insider threat solutions, today announced that their Reveal Platform is the first Insider Risk Management solution to automatically map detection events to MITRE Engenuity Center for Threat-Informed Defense's ("Center") expanded Insider Threat Knowledge Base (ITKB 2.0) .
  • The ITKB 2.0 is the first of its kind to offer an evidence-based, multi-organizational and publicly-available compendium of insider threat tactics, techniques, and procedures (TTPs).
  • "With Reveal, and in partnership with MITRE CTID, we are setting a new standard for data protection and insider threat mitigation," said John Stringer, Head of Product at Next DLP.
  • To learn more about Next's alignment with the MITRE Insider Threat Knowledge Base, we've put together an informative blog post available to read now.

Actona Group Partners with Makersite to Accelerate Sustainability Goals and Lead Industry in Scope 3 Emissions Reporting

Retrieved on: 
Tuesday, April 30, 2024

The collaboration underscores Actona Group's commitment to significantly enhancing its sustainability and business practices across all aspects of its operations.

Key Points: 
  • The collaboration underscores Actona Group's commitment to significantly enhancing its sustainability and business practices across all aspects of its operations.
  • By leveraging Makersite's cutting-edge capabilities, Actona Group is ready to achieve detailed insight into product-specific Scope 3 emissions, setting a new industry standard in environmental accountability.
  • "Partnering with Makersite represents a significant step forward in our sustainability journey," said Jimmi King Mortensen, President and CEO of Actona Group.
  • "Our solution has enabled Actona Group to track emissions right down to each individual purchased part and material."

Health Equity Cannot Be Achieved Without Data Equity

Retrieved on: 
Monday, April 29, 2024

CHICAGO, April 29, 2024 /PRNewswire/ -- To reduce inequities in the U.S. health system, the Data Equity Coalition is calling for standardized data collection methods around race, ethnicity, language (REL), sexual orientation, gender identity (SOGI) and disability status through a new series of issue briefs.

Key Points: 
  • "Data standardization is crucial to advancing health equity and creating a better system of health—one centered on trust," said Blue Cross Blue Shield Association President and CEO, Kim Keck.
  • Data disaggregation allows us to detect differences, if they exist, between and within populations, and to design policies and programs that can help eliminate health disparities and achieve health equity."
  • More equitable data is key to addressing the health care system's persistent inequities—especially as it relates to mental health care access for members of underserved communities."
  • "The National LGBTQ Task Force urges the expansion and improvement of sexual orientation, gender identity and sex characteristics data collection to improve health equity.

AiRISTA Ranked in 2024 Gartner® Critical Capabilities Report for Indoor Location Services

Retrieved on: 
Monday, April 29, 2024

TIMONIUM Md., April 29, 2024 /PRNewswire/ -- AiRISTA, a global leader in real time location services (RTLS), today announced that it has been recognized in 2024 Gartner Critical Capabilities for Indoor Location Services Report. This Critical Capabilities research is a companion to Gartner's Magic Quadrant for Indoor Location Services. It scores 18 vendors across six Use Cases designed to reflect the primary evaluation criteria Gartner recommends to I&O leaders.

Key Points: 
  • AiRISTA was ranked #1 in the People Tracking Use Case in the Gartner Critical Capabilities for Indoor Location Services report.
  • TIMONIUM Md., April 29, 2024 /PRNewswire/ -- AiRISTA , a global leader in real time location services (RTLS), today announced that it has been recognized in 2024 Gartner Critical Capabilities for Indoor Location Services Report.
  • "AiRISTA is honored to be recognized once again by Gartner in the 2024 Critical Capabilities Report for Indoor Location Services," said Sy Sajjad, CEO and founder of AiRISTA.
  • AiRISTA is recognized in the 2024 Gartner Critical Capabilities Report for Indoor Location Services report.

EQS-News: Volta Medical Announces Late-Breaking TAILORED-AF Randomized Clinical Trial Results at Heart Rhythm 2024 in Boston, MA, USA

Retrieved on: 
Friday, May 3, 2024

This AI companion technology may help electrophysiologists to optimize catheter-ablation procedures for complex arrhythmias, including persistent AF.

Key Points: 
  • This AI companion technology may help electrophysiologists to optimize catheter-ablation procedures for complex arrhythmias, including persistent AF.
  • Professor Isabel Deisenhofer will share findings from the TAILORED-AF clinical trial.
  • Volta Medical is hosting a Rhythm Theater presentation, “The Future of AI Implementation in AF Ablation Procedures”.
  • Volta Medical will exhibit at booth #328, featuring a demonstration of the Volta AF-Xplorer™ software, while a tech suite at #TS266 will spotlight the company’s product vision.

VAT releases its Sustainability Report 2023, showing progress against inaugural mid-term targets for Greenhouse Gas emissions and employee diversity targets set in 2022

Retrieved on: 
Friday, May 3, 2024

VAT releases its Sustainability Report 2023, showing progress against inaugural mid-term targets for Greenhouse Gas emissions and employee diversity targets set in 2022

Key Points: 
  • VAT releases its Sustainability Report 2023, showing progress against inaugural mid-term targets for Greenhouse Gas emissions and employee diversity targets set in 2022
    VAT, the leading global supplier of high-end vacuum valves, published its third annual Sustainability Report today, providing stakeholders with a broader and more robust range of environment, social and governance (ESG) metrics, the progress made versus its inaugural ESG targets and an overview over its external ESG ratings.
  • The execution of the ESG measures and targets from the company’s mid-term strategic plan back in 2022 have gained companywide traction.
  • “VAT includes sustainability considerations in how we operate the business, and we have embedded ESG performance criteria in our strategic plan,” said Martin Komischke, Chairman of VAT’s Board of Directors.
  • The report is compliant with the Swiss directive on non-financial disclosure, applicable going forward for the first time for the business year 2023.

Tealium releases solutions for enhancing AI performance with consented, enriched, real-time data

Retrieved on: 
Thursday, May 2, 2024

SAN DIEGO, May 02, 2024 (GLOBE NEWSWIRE) -- Tealium , the largest independent and most trusted customer data platform (CDP), has released Tealium for AI , a suite of customer data collection, management, and activation solutions that allow enterprises to fuel their AI models with consented, filtered, and enriched data for better value and performance.

Key Points: 
  • SAN DIEGO, May 02, 2024 (GLOBE NEWSWIRE) -- Tealium , the largest independent and most trusted customer data platform (CDP), has released Tealium for AI , a suite of customer data collection, management, and activation solutions that allow enterprises to fuel their AI models with consented, filtered, and enriched data for better value and performance.
  • Tealium helps enterprises unlock the full potential of AI with our real-time, compliance-driven, first-party data solutions.
  • Data Governance: Tealium’s customer data solutions, including consent integration, encryption, filtering, and orchestration, help mitigate AI compliance risks, like blocking non-consented data from AI models.
  • Contextual Data Labeling: Tealium provides tools for labeling customer data and enriching it with contextual information, such as metadata, visitor profiles, and audience badges, to add relevance, and maximize AI performance.

Fleetio and Samsara Provide Tips for Managing Aging Government Fleets at Government Fleet Expo

Retrieved on: 
Thursday, May 2, 2024

“How to Manage Aging Government Fleets with Limited Budgets” will address the challenges government fleet managers face navigating rising costs and maximizing the life of aging vehicles.

Key Points: 
  • “How to Manage Aging Government Fleets with Limited Budgets” will address the challenges government fleet managers face navigating rising costs and maximizing the life of aging vehicles.
  • “Government fleets are the backbone of essential service delivery in our communities,” said Simpson.
  • Logan Kiernan, Field Sales Engineer, Samsara, who will discuss how real-time sensor data provides actionable insights that improve fleet health and extend asset life.
  • Tom Rowlings, Assistant Fleet Manager, City of Cambridge, who will provide real-world examples of how the City of Cambridge utilizes data and technology to optimize the management of its municipal fleet.

Cribl Signs Strategic Collaboration Agreement with AWS to Deliver Data Solutions for IT and Security

Retrieved on: 
Thursday, April 25, 2024

“This new agreement with AWS is another major step toward delivering customers choice and control over their rapidly growing IT and security data,” said Zac Kilpatrick, Vice President of Global Channels at Cribl.

Key Points: 
  • “This new agreement with AWS is another major step toward delivering customers choice and control over their rapidly growing IT and security data,” said Zac Kilpatrick, Vice President of Global Channels at Cribl.
  • Continued innovation with AWS to give customers freedom through its integration with Amazon Security Lake and showcasing Cribl Search capabilities.
  • “Thanks to Cribl, we’re able to streamline data transformation to OCSF and ingestion to Amazon Security Lake, and we’ve gained enhanced data search capabilities within Amazon Security Lake.
  • In addition to the integration with Amazon Security Lake, Cribl has achieved the AWS Data and Analytics Competency and AWS Security Competency designations.

Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B

Retrieved on: 
Wednesday, April 24, 2024

SYDNEY, AUSTRALIA, April 24, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces preliminary topline results from Cohort B of the TACTI-003 (KEYNOTE-PNC-34) Phase IIb trial evaluating eftilagimod alpha (efti) in combination with MSD’s anti-PD-1 therapy KEYTRUDA® (pembrolizumab) as first-line treatment of recurrent/metastatic head and neck squamous cell carcinoma patients (1L HNSCC) with negative PD-L1 expression.

Key Points: 
  • Head and neck squamous cell carcinomas are a heterogenous disease that represent a high unmet medical need regardless of PD-L1 expression.
  • A total of 33 patients with recurrent or metastatic HNSCC have been enrolled into Cohort B.
  • The final number of evaluable patients in Cohort B is expected to be higher and additional data, including complete response rate, will be released together with Cohort A data.
  • Patients in Cohort A are stratified by CPS >1, CPS 1-19, and CPS >20, and the clinical results for these three CPS groups will be evaluated.